| # | Drug | Count |
|---|---|---|
| 0 | FLUDARABINE PHOSPHATE | 17 |
| 1 | MYCOPHENOLATE MOFETIL | 17 |
| 2 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 17 |
| 3 | THIOTEPA | 16 |
| 4 | AMPHOTERICIN B | 15 |
| 5 | METHYLPREDNISOLONE | 15 |
| 6 | METRONIDAZOLE | 15 |
| 7 | CEFOTAXIME | 14 |
| 8 | CEFOTAXIME INJECTION | 14 |
| 9 | LEVETIRACETAM | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC | 1 | 0.0345 |
| 1 | CHLORINE | 1 | 0.0159 |
| 2 | CASTOR OIL | 1 | 0.0052 |
| 3 | CEFOTAXIME INJECTION | 14 | 0.0032 |
| 4 | SODIUM NITROPRUSSIDE | 1 | 0.0026 |
| 5 | PROTHROMBIN, COAGULATION FACTOR VII HUMAN, COAGULATION FACTOR IX HUMAN, COAGULATION FACTOR X HUMAN, PROTEIN C, PROTEIN S HUMAN, AND WATER | 1 | 0.0018 |
| 6 | THIOTEPA | 16 | 0.0016 |
| 7 | AMPHOTERICIN B | 15 | 0.0012 |
| 8 | SMOFLIPID | 1 | 0.0011 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 8 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 39 |
| 1 | Alkylating Drug [EPC] | 22 |
| 2 | Polyene Antifungal [EPC] | 17 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 15 |
| 4 | Nitroimidazole Antimicrobial [EPC] | 15 |
| 5 | Azole Antifungal [EPC] | 10 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 10 |
| 7 | Proteasome Inhibitor [EPC] | 9 |
| 8 | Glycopeptide Antibacterial [EPC] | 8 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipid-based Polyene Antifungal [EPC] | 15 | 0.0012 |
| 1 | CD33-directed Immunoconjugate [EPC] | 3 | 0.0008 |
| 2 | Polyene Antifungal [EPC] | 17 | 0.0004 |
| 3 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 4 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 5 | Vitamin K [EPC] | 3 | 0.0003 |
| 6 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 15 | 0.0002 |
| 8 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |
| 9 | Antimalarial [EPC] | 2 | 0.0002 |